By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dow Pharmaceutical Sciences 

1330A Redwood Way

Petaluma  California  94954  U.S.A.
Phone: 707-793-2600 Fax: 707-793-0145


Company News
Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International (VRX) is Completed 1/9/2009 11:51:56 AM
Valeant Pharmaceuticals International (VRX) Completes Acquisition of Dow Pharmaceutical Sciences 1/2/2009 10:53:04 AM
Valeant Pharmaceuticals International (VRX) to Acquire Dow Pharmaceutical Sciences for $285 Million 12/10/2008 6:29:04 AM
Dow Pharmaceutical Sciences to Present Scientific Poster at American Association of Pharmaceutical Scientists Evaluating the Affect of Flow Rate, Tissue Thickness and Receptor Phase Type on Drug Penetration When Appied Topically to Human Dermatomed and Dermis Only Skin 10/30/2008 11:08:19 AM
Dow Pharmaceutical Sciences Expands Clinical Labeling Capabilities in Petaluma, California 9/4/2008 8:25:29 AM
Kaken Pharmaceuticals To License Its Antifungal Compound KP-103 To Dow Pharmaceutical Sciences 5/11/2006 3:18:58 PM
DOR BioPharma, Inc. (DOR) And Dow Pharmaceutical Sciences Complete Feasibility Study For Production Of BT-VACC 11/17/2005 11:51:42 AM
FDA Receives Dow Pharmaceutical Sciences Approval Of NDA For Galderma's Clobex(R) Spray For Moderate-To-Severe Plaque Psoriasis 11/2/2005 11:00:57 AM
Dr. Daniel Bucks, Director Of The Skin Biology And Drug Delivery Laboratory At Dow Pharmaceutical Sciences, Speaks On Skin Permeation Enhancement Techniques At AAPS Convention In Baltimore 10/19/2005 5:12:23 PM
Dow Pharmaceutical Sciences Appoints Sandra Calman, MD As Director Of Clinical Research For The Solano Clinical Research Unit 10/19/2005 5:12:15 PM